Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Calcitriol + Magnesium + Pyridoxine + Quercetin + Sodium nucleinate + Sodium deoxeribonucleate
- Development stage
- Unknown
- Lead developer
- MIPO Clinic
- Modality
- Small Molecules
- Administration
- Oral, Sublingual
01
Overview
This multi-component immunomodulatory and rehabilitative regimen was developed or utilized by the **MIPO Clinic** for the supportive care of patients with **non-small cell lung cancer (NSCLC)**. The combination consists of **calcitriol** (a vitamin D receptor agonist), **magnesium lactate** with **pyridoxine** (Vitamin B6), the plant flavonoid **quercetin**, and nucleic acid-based immunostimulants including **sodium nucleinate** and **sodium deoxeribonucleate** (marketed as Naderin). The regimen is designed to modulate neutrophil function—specifically enhancing phagocytosis, mitochondrial activity, and liposomal function—while providing antioxidant support and detoxification. It is primarily investigated for its potential to improve quality of life and extend life expectancy in oncologic patients during the restorative treatment and rehabilitation phase.
- Brand names
- Naderin
- Other names
- sodium nucleinate and immunomodulators in NSCLC rehabilitationo-MIPO Clinic-non-small cell lung cancer
02
Targets
VDR (Vitamin D receptor)
Beyond the preview
Go deeper on Calcitriol + Magnesium + Pyridoxine + Quercetin + Sodium nucleinate + Sodium deoxeribonucleate.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Calcitriol + Magnesium + Pyridoxine + Quercetin + Sodium nucleinate + Sodium deoxeribonucleate.